Solventum Corporation (solv)
SOLV — Company Overview
Solventum Corporation (SOLV) is a large-cap company in the Healthcare sector, operating in Medical Instruments & Supplies.
| Ticker | SOLV |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Exchange | NYQ |
| Market cap | $15.04B |
| Last price | $88.37 |
| Size category | Large Cap |
SOLV — Business Description
Solventum Corporation (SOLV) operates in Medical Instruments & Supplies within the broader Healthcare market. Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodont…
Official website: https://www.solventum.com.
SOLV — Investment Thesis
The investment thesis for Solventum Corporation (SOLV) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 2.2% year-over-year (public data).
- Trailing P/E near 10.80× suggests a value-oriented earnings multiple.
- Equity market capitalization is approximately $15.04B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
SOLV — Financial Health
Financial health for Solventum Corporation (SOLV) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin of 17.3% indicates solid bottom-line conversion. Positive free cash flow of $489.00M supports balance-sheet flexibility. Debt-to-equity of 110.31 warrants monitoring in a higher-rate environment.
| Trailing P/E | 10.80× |
| Forward P/E | 12.22× |
| Price / Sales | 1.81× |
| Price / Book | 3.13× |
| Gross margin | 54.8% |
| Operating margin | 9.8% |
| Profit margin | 17.3% |
| Return on equity | 34.0% |
| Debt / Equity | 110.31 |
| Free cash flow | $489.00M |
SOLV — Growth Outlook
Growth outlook for Solventum Corporation (SOLV) depends on demand trends in Medical Instruments & Supplies and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 2.2% suggests steady but measured expansion.
- Earnings growth of 3.9% year-over-year supports improving profitability.
- Price is 6.1% below the 52-week high.
SOLV — Competitive Position
Solventum Corporation (SOLV) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Instruments & Supplies.
- Market capitalization of $15.04B places SOLV among large-cap peers.
- Gross margin near 54.8% may reflect pricing power or favorable mix.
SOLV — Strengths
Strengths for Solventum Corporation (SOLV) inferred from public financial metrics:
- Earnings growth of 3.9% year-over-year.
- Return on equity near 34.0% — efficient use of shareholder capital.
- Gross margin of 54.8% supports competitive unit economics.
- Positive free cash flow ($489.00M).
- Large Cap scale ($15.04B) may provide distribution and funding advantages.
- Price near 52-week highs — positive price momentum on public markets.
SOLV — Weaknesses
Weaknesses and pressure points for Solventum Corporation (SOLV) based on available data:
Insufficient public data to assess this factor.
SOLV — Opportunities
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
SOLV — Risks
- Standard market, regulatory, competitive, and execution risks apply to all public equities.
SOLV — Summary
Solventum Corporation (SOLV) is a large-cap Healthcare company focused on Medical Instruments & Supplies, listed on NYQ. Last price $88.37 with market cap $15.04B. Trailing P/E 10.80×. Revenue grew 2.2% year-over-year per public data. Notable strengths include earnings growth of 3.9% year-over-year. Public estimates and earnings snapshots for Solventum Corporation are on this site; ownership, live news, and deeper models remain in Vest Terminal.
Start Free — open SOLV in Vest Terminal
Access live data, filings, ownership, and analysis for Solventum Corporation.
Solventum Corporation FAQ
What does Solventum Corporation (SOLV) do?
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Inf…
What is SOLV's P/E ratio?
Solventum Corporation has a trailing P/E of 10.80× based on publicly available market data.
Does SOLV pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is SOLV in?
Solventum Corporation is classified in Healthcare (Medical Instruments & Supplies) on NYQ.
What is SOLV's market capitalization?
Approximate market cap: $15.04B.
What are the main risks for SOLV?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of SOLV?
Potential positives include earnings growth of 3.9% year-over-year, return on equity near 34.0% — efficient use of shareholder capital.
Where can I get analyst estimates for SOLV?
Public analyst price targets and consensus for Solventum Corporation are on the free /stocks/solv/estimates page. Deeper estimate history and models are available in Vest Terminal.